MedTrace Logo

GLP-1: Acute Effects on Kidney Function in Healthy Men

NCT01333163 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2011-12-15

No results posted yet for this study

Summary

The purpose of this study is to investigate how Glucagon-Like Peptide 1 (GLP-1) affects kidney function in healthy young men. The hypothesis is that GLP-1 induces a positive effect on kidney hemodynamics.

Conditions

  • Kidney Functional

Interventions

BIOLOGICAL

Human GLP-1 (7-36) amide

2 hour IV infusion, 1,5pmol/min/kg.

BIOLOGICAL

Isotone NaCl

2 hours IV infusion.

Sponsors & Collaborators

Principal Investigators

  • Jeppe Skov, MD · University of Aarhus

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01333163 on ClinicalTrials.gov